Harbin Pharmaceutical Group Co (SHSE:600664) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co Change In Payables And Accrued Expense?

Harbin Pharmaceutical Group Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Harbin Pharmaceutical Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Harbin Pharmaceutical Group Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Harbin Pharmaceutical Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Harbin Pharmaceutical Group Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Harbin Pharmaceutical Group Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Pharmaceutical Group Co Change In Payables And Accrued Expense Chart

Harbin Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Harbin Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Harbin Pharmaceutical Group Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Harbin Pharmaceutical Group Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018

Website

http://www.hayao.com

Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.

Executives

Liu Bo	senior management
Xia Ji Cheng	senior management
Qiu Fang Ju	Supervisors
Li Bang Dong	senior management
Jiang Hai Tao	senior management
Meng Xiao Dong	senior management
Lin Guo Ren	senior management
Wang Hai Sheng	senior management
Xu Hai Ying	Directors, senior managers
Liang Chen	senior management
Wang Peng Hao	senior management
Xiao Qiang	senior management
Bian Ke	Supervisors
Zhou Xing	senior management
Wei Shuang Ying	senior management

Harbin Pharmaceutical Group Co Headlines

No Headlines